Search

everythinglearnresearchcommunity

for

Search:↓

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Deucravacitinib helped a man regrow hair significantly.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Oral Apremilast effectively treats alopecia areata in most patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib effectively treats Alopecia Areata.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Certain hair and scalp features can predict the severity of alopecia areata.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.